Christina Larkin

2019

In 2019, Christina Larkin earned a total compensation of $943.3K as Chief Operating Officer at Spero Therapeutics, a 77% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$158,000
Option Awards$271,837
Salary$394,167
Stock Awards$118,493
Other$792
Total$943,289

Larkin received $394.2K in salary, accounting for 42% of the total pay in 2019.

Larkin also received $158K in non-equity incentive plan, $271.8K in option awards, $118.5K in stock awards and $792 in other compensation.

Rankings

In 2019, Christina Larkin's compensation ranked 9,537th out of 13,971 executives tracked by ExecPay. In other words, Larkin earned more than 31.7% of executives.

ClassificationRankingPercentile
All
9,537
out of 13,971
32nd
Division
Manufacturing
3,835
out of 5,698
33rd
Major group
Chemicals And Allied Products
1,455
out of 2,197
34th
Industry group
Drugs
1,243
out of 1,883
34th
Industry
Pharmaceutical Preparations
923
out of 1,395
34th
Source: SEC filing on September 30, 2020.

Larkin's colleagues

We found two more compensation records of executives who worked with Christina Larkin at Spero Therapeutics in 2019.

2019

Ankit Mahadevia

Spero Therapeutics

Chief Executive Officer

2019

David Melnick

Spero Therapeutics

Chief Medical Officer

News

You may also like